Loading…

Comprehensive Proteomic Analysis of Human Pancreatic Juice

Proteomic technologies provide an excellent means for analysis of body fluids for cataloging protein constituents and identifying biomarkers for early detection of cancers. The biomarkers currently available for pancreatic cancer, such as CA19-9, lack adequate sensitivity and specificity contributin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of proteome research 2004-09, Vol.3 (5), p.1042-1055
Main Authors: Grønborg, Mads, Bunkenborg, Jakob, Kristiansen, Troels Zakarias, Jensen, Ole Nørregaard, Yeo, Charles J, Hruban, Ralph H, Maitra, Anirban, Goggins, Michael G, Pandey, Akhilesh
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Proteomic technologies provide an excellent means for analysis of body fluids for cataloging protein constituents and identifying biomarkers for early detection of cancers. The biomarkers currently available for pancreatic cancer, such as CA19-9, lack adequate sensitivity and specificity contributing to late diagnosis of this deadly disease. In this study, we carried out a comprehensive characterization of the “pancreatic juice proteome” in patients with pancreatic adenocarcinoma. Pancreatic juice was first fractionated by 1-dimensional gel electrophoresis and subsequently analyzed by liquid chromatography tandem mass spectrometry (LC−MS/MS). A total of 170 unique proteins were identified including known pancreatic cancer tumor markers (e.g., CEA, MUC1) and proteins overexpressed in pancreatic cancers (e.g., hepatocarcinoma−intestine−pancreas/pancreatitis-associated protein (HIP/PAP) and lipocalin 2). In addition, we identified a number of proteins that have not been previously described in pancreatic juice (e.g., tumor rejection antigen (pg96) and azurocidin). Interestingly, a novel protein that is 85% identical to HIP/PAP was identified, which we have designated as PAP-2. The proteins identified in this study could be directly assessed for their potential as biomarkers for pancreatic cancer by quantitative proteomics methods or immunoassays. Keywords: liquid chromatography tandem mass spectrometry (LC−MS/MS) • functional annotation • body fluid
ISSN:1535-3893
1535-3907
DOI:10.1021/pr0499085